Strategies to increase detection of hemochromatosis

被引:15
作者
McDonnell, SM
Witte, DL
Cogswell, ME
McIntyre, R
机构
[1] Ctr Dis Control & Prevent, Div Int Hlth, Atlanta, GA 30303 USA
[2] Lab Control Ltd, Ottumwa, IA USA
关键词
D O I
10.7326/0003-4819-129-11_Part_2-199812011-00010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
As part of the iron Overload, Public Health and Genetics conference, sponsored by the Centers for Disease Control and Prevention in March 1997, a working group was convened to consider strategies to increase early case detection of hemochromatosis. This group emphasized that the primary public health goal should be to diagnose hemochromatosis before symptoms appear. To reach this goal, education and action need to be targeted to physicians and other health care workers, laboratorians, administrators, payers, and the public. Strategies to disseminate updated information and increase early case detection were prioritized according to expected effectiveness. Strategies targeting physicians are 1) to identify national and local physician-leaders and 2) to educate physicians about hemochromatosis in basic, graduate specialty, and continuing medical education. Strategies aimed at the health system are 1) to encourage laboratories to provide the transferrin saturation test as part of routine laboratory panels and 2) to work with policymakers and payers to allow reimbursement for case detection. Finally, public education is recommended to increase lay support for the early diagnosis of hemochromatosis. Attempts to educate the public should be aimed first at persons who receive diagnoses of hemochromatosis in order to ensure that they are properly treated and then at asymptomatic persons who could be screened as part of health appraisals. Although identifying physician-leaders and educating physicians are the highest priorities, physicians should not be targeted at the exclusion of payers and the public. Simultaneous efforts to reach all groups in appropriate ways should be initiated to provide the interest and infrastructure necessary to decrease morbidity and mortality from hemochromatosis.
引用
收藏
页码:987 / 992
页数:6
相关论文
共 65 条
[1]   SCREENING BLOOD-DONORS FOR HEREDITARY HEMOCHROMATOSIS - DECISION-ANALYSIS MODEL-BASED ON A 30-YEAR DATABASE [J].
ADAMS, PC ;
GREGOR, JC ;
KERTESZ, AE ;
VALBERG, LS .
GASTROENTEROLOGY, 1995, 109 (01) :177-188
[2]   Evolving expression of hereditary hemochromatosis [J].
Adams, PC ;
Valberg, LS .
SEMINARS IN LIVER DISEASE, 1996, 16 (01) :47-54
[3]  
Alper J S, 1994, J Public Health Policy, V15, P345, DOI 10.2307/3342910
[4]   IRON OVERLOAD IN AFRICAN-AMERICANS [J].
BARTON, JC ;
EDWARDS, CQ ;
BERTOLI, LF ;
SHROYER, TW ;
HUDSON, SL .
AMERICAN JOURNAL OF MEDICINE, 1995, 99 (06) :616-623
[5]   Diagnosis of hemochromatosis probands in a community hospital [J].
Barton, JC ;
Barton, NH ;
Alford, TJ .
AMERICAN JOURNAL OF MEDICINE, 1997, 103 (06) :498-503
[6]   Management of hemochromatosis [J].
Barton, JC ;
McDonnell, SM ;
Adams, PC ;
Brissot, P ;
Powell, LW ;
Edwards, CQ ;
Cook, JD ;
Kowdley, KV .
ANNALS OF INTERNAL MEDICINE, 1998, 129 (11) :932-939
[7]   SOCIOBEHAVIORAL DETERMINANTS OF COMPLIANCE WITH HEALTH AND MEDICAL CARE RECOMMENDATIONS [J].
BECKER, MH ;
MAIMAN, LA .
MEDICAL CARE, 1975, 13 (01) :10-24
[8]  
Blaine J R, 1997, Mo Med, V94, P612
[9]  
BOTHWELL TH, 1982, CECILS TXB MED, P1128
[10]  
Bradley L A, 1996, J Med Screen, V3, P178